SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Makers Laboratories - Quaterly Results

14 Aug 2022 Evaluate
The sales for the June 2022 quarter moved down -34.71% to Rs. 96.67 millions as compared to Rs. 148.07 millions during the year ago period.The Net Loss for the quarter ended June 2022 is Rs. -22.73 millions as compared to Net Profit of Rs. 2.96 millions of corresponding quarter ended June 2021Operating profit Margin for the quarter ended June 2022 slipped to -13.88% as compared to 12.44% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 96.67 148.07 -34.71 96.67 148.07 -34.71 524.09 444.11 18.01
Other Income 1.34 0.56 139.29 1.34 0.56 139.29 8.48 4.14 104.83
PBIDT -13.88 12.44 -211.58 -13.88 12.44 -211.58 38.95 37.11 4.96
Interest 3.69 4.33 -14.78 3.69 4.33 -14.78 16.75 15.89 5.41
PBDT -17.57 8.11 -316.65 -17.57 8.11 -316.65 22.20 21.22 4.62
Depreciation 4.79 4.62 3.68 4.79 4.62 3.68 19.07 41.96 -54.55
PBT -22.36 3.49 -740.69 -22.36 3.49 -740.69 3.13 -20.74 -115.09
TAX 0.37 0.53 -30.19 0.37 0.53 -30.19 1.41 -4.57 -130.85
Deferred Tax 0.37 0.53 -30.19 0.37 0.53 -30.19 1.08 -2.90 -137.24
PAT -22.73 2.96 -867.91 -22.73 2.96 -867.91 1.72 -16.17 -110.64
Equity 59.00 49.17 19.99 59.00 49.17 19.99 49.17 49.17 0.00
PBIDTM(%) -14.36 8.40 -270.90 -14.36 8.40 -270.90 7.43 8.36 -11.06

Makers Laboratories Share Price

155.80 -4.35 (-2.72%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×